GoodRx CEO Says Pandemic Didn't Impact Drug Prices

The video discusses the impact of COVID-19 on industries, particularly telehealth and drug pricing. It highlights how telehealth grew during the pandemic and the challenges of drug pricing in the U.S. GoodRX's growth and acquisitions are explored, along with trends in telehealth usage post-pandemic. The video concludes with a discussion on the need for systemic changes in drug pricing.

What are some of the long-term changes in healthcare delivery that may persist post-pandemic?

How do drug prices in the U.S. compare to those in other countries, according to the discussion?

What role do consumers play in addressing the issues of drug pricing?